BECN1 and breast carcinoma: Black phosphorus quantum dots (QDs) disguised with a platelet membrane provided Hederagenin (HED) in breast tumor therapy (MCF-7 cells), and these HED-loaded QDs increased Beclin-1 and LC3-II to enhance the HED’s antitumor efficacy against breast cancer [120].